News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Incyte Corporation (INCY) Says Psoriasis Drug Meets Main Goal



9/22/2009 7:23:28 AM

Bookmark and Share

Reuters -- Incyte Corp said its topical treatment INCB18424 for psoriasis met the main and secondary goals in a mid-stage trial, sending its shares up nearly 11 percent.

Read at Reuters
Read at Wall Street Journal
Read at Forbes
Read at RTT News
Read at Street Insider

Related News

comments powered by Disqus
   
Psoriasis

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES